Habib J. Dable - 08 Aug 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
08 Aug 2022
Net transactions value
$0
Form type
4
Filing time
10 Aug 2022, 17:57:37 UTC
Previous filing
27 Jun 2022
Next filing
22 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALBO Stock Options (Right to buy) Award $0 +16,000 $0.000000 16,000 08 Aug 2022 Common Stock 16,000 $25.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in equal annual installments over three years from August 8, 2022 (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant), subject to the director's continued service on the issuer's board of directors on the vesting date.